EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial).

Maeve A Hennessy, Constantine Gatsonis, Heather Jacene, Roisin M Connolly, Brian L Burnette, Erica M Stringer-Reasor, Justin Romanoff, Alexander Taurone, Ciara C O'Sullivan, Huong T Le-Petross, Vered Stearns, Amy M Fowler, Shou-Ching Tang, Karla A Sepulveda, Angela M DeMichele